IUdR/BUdR Cell Cycle Labelling
NCT00042250
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Hematologic Malignancies
Interventions
DRUG:
Chemotherapy for hematologic malignancy
Sponsor
M.D. Anderson Cancer Center